Papers
5
Total Citations
34
H-Index
4
About
Dr. Yuval Elkun is a urologic surgeon and researcher whose work is reshaping perioperative care in robotic-assisted urologic oncology. His primary research focuses on optimizing outcomes after robot-assisted radical cystectomy (RARC) and partial nephrectomy, with particular emphasis on thromboembolic prophylaxis, infection prevention, and same-day discharge protocols. Dr. Elkun’s landmark study, “Outcomes from a prospectively implemented protocol using apixaban after robot-assisted radical cystectomy” (2023, 15 citations), demonstrated that oral apixaban is a safe and effective alternative to injectable enoxaparin for venous thromboembolism prevention, potentially simplifying post-surgical care. He further advanced the field by comparing multi-port versus single-port robotic partial nephrectomy with same-day discharge (2025, 7 citations), showing that surgical approach impacts recovery. His work on antibiogram-directed prophylaxis and intracorporeal urinary diversion (2023, 6 citations) has helped reduce postoperative infections. With over 30 cumulative citations, Dr. Elkun’s contributions are guiding evidence-based protocols that enhance patient safety and accelerate recovery in robotic urologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5